Home Healthcare Pharmaceuticals Retinal Vein Occlusion Market

Retinal Vein Occlusion Market Size, Share & Trends Analysis Report By Disease Type (Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)), By Treatment (Anti-vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, Other Treatments), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Other End Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 30, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Retinal Vein Occlusion Market Size Analysis
    1. Introduction
    2. Retinal Vein Occlusion Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Central Retinal Vein Occlusion (CRVO)
      2. Branch Retinal Vein Occlusion (BRVO)
    3. Retinal Vein Occlusion Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
      2. Corticosteroid Drugs
      3. Other Treatments
    4. Retinal Vein Occlusion Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other End Users
  7. North America Retinal Vein Occlusion Market Size Analysis
    1. Introduction
    2. Retinal Vein Occlusion Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Central Retinal Vein Occlusion (CRVO)
      2. Branch Retinal Vein Occlusion (BRVO)
    3. Retinal Vein Occlusion Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
      2. Corticosteroid Drugs
      3. Other Treatments
    4. Retinal Vein Occlusion Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other End Users
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
  8. Europe Retinal Vein Occlusion Market Size Analysis
    1. Introduction
    2. Retinal Vein Occlusion Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Central Retinal Vein Occlusion (CRVO)
      2. Branch Retinal Vein Occlusion (BRVO)
    3. Retinal Vein Occlusion Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
      2. Corticosteroid Drugs
      3. Other Treatments
    4. Retinal Vein Occlusion Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other End Users
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    7. France
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
  9. APAC Retinal Vein Occlusion Market Size Analysis
    1. Introduction
    2. Retinal Vein Occlusion Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Central Retinal Vein Occlusion (CRVO)
      2. Branch Retinal Vein Occlusion (BRVO)
    3. Retinal Vein Occlusion Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
      2. Corticosteroid Drugs
      3. Other Treatments
    4. Retinal Vein Occlusion Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other End Users
    5. China
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    8. India
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
  10. Middle East and Africa Retinal Vein Occlusion Market Size Analysis
    1. Introduction
    2. Retinal Vein Occlusion Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Central Retinal Vein Occlusion (CRVO)
      2. Branch Retinal Vein Occlusion (BRVO)
    3. Retinal Vein Occlusion Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
      2. Corticosteroid Drugs
      3. Other Treatments
    4. Retinal Vein Occlusion Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other End Users
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
  11. LATAM Retinal Vein Occlusion Market Size Analysis
    1. Introduction
    2. Retinal Vein Occlusion Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Central Retinal Vein Occlusion (CRVO)
      2. Branch Retinal Vein Occlusion (BRVO)
    3. Retinal Vein Occlusion Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
      2. Corticosteroid Drugs
      3. Other Treatments
    4. Retinal Vein Occlusion Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Other End Users
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Central Retinal Vein Occlusion (CRVO)
        2. Branch Retinal Vein Occlusion (BRVO)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
        2. Corticosteroid Drugs
        3. Other Treatments
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Other End Users
  12. Competitive Landscape
    1. Retinal Vein Occlusion Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Regeneron Pharmaceuticals, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Hoffmann‑La Roche Ltd. / Genentech
    3. Novartis AG
    4. Bayer AG
    5. AbbVie Inc. (Allergan)
    6. Aerie Pharmaceuticals, Inc.
    7. Kodiak Sciences Inc.
    8. Chugai Pharmaceutical Co., Ltd.
    9. Taiwan Liposome Company, Ltd.
    10. Outlook Therapeutics, Inc.
    11. CalciMedica Inc.
    12. Pfizer Inc.
    13. Alimera Sciences, Inc.
    14. Graybug Vision, Inc.
    15. IRIDEX Corporation
    16. Lumenis
    17. Nidek Co., Ltd.
    18. Annexin Pharmaceuticals AB
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.